Study of BW-50218 in Healthy Participants

NCT07401472 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Participants Study

Interventions

DRUG: BW-50218 Injection
DRUG: Saline (0.9% NaCl)

Sponsor

Shanghai Argo Biopharmaceutical Co., Ltd.